For example, we and others have reported frequent promoter hypermethylation at RASSF1, CDKN2A, DAPK, MIPOL1, WIF1, UCHL1, THY1, and PCDH10 in NPC 10–16. This evidence concerns the gene RASSF1 and nasopharyngeal carcinoma.